Zhongnan Medical Journal Press

Home Results

A total of 2057 result was found. Results that relate to R

Research on quality management, responsibilities and regulatory measures of the domestic responsible person for drugs

Published on Frontiers in Pharmaceutical Sciences 2025,29(12):2088-2097.
1267 times 190 times

WANG Ying WANG Guangping

Imported drugs Domestic responsible entity Overseas marketing authorization holders Quality management responsibility Responsible entity Obligation Challenge Supervision
Details
Research progress on the chemical constituents and pharmacological effects of Chinese yam

Published on Frontiers in Pharmaceutical Sciences 2025,29(12):2098-2111.
1605 times 244 times

ZHENG Xiaonan SUN Cuige DI Qing HU Liping ZHAO Xiangxuan

Chinese yam Chemical composition Pharmacological effects Chronic atrophic gastritis Drug target Network pharmacology Targeted drugs Natural products
Details
Research progress of the chemical composition and pharmacological effects of Gastrodia elata Bl.

Published on Frontiers in Pharmaceutical Sciences 2025,29(12):2112-2122.
2426 times 356 times

LIU Zhenzhen YAN Jingyi LI Ganpeng LIU Xin REN Feng

Gastrodia elata Bl. Chemical composition Gastrodin Polysaccharide Organic acids Sterol Pharmacological effect Protective effect Research progress
Details
Research progress on the pharmacological effects and mechanisms of Bletilla striata in promoting diabetic foot ulcer healing

Published on Frontiers in Pharmaceutical Sciences 2025,29(12):2123-2136.
1317 times 219 times

SUN Ping ZHANG Yufeng LI Chenxia ZHANG Chenning

Bletilla striata Diabetic foot ulcer Pharmacological effects Research progress Wound healing Hyperglycemia Hemostasis
Details
Research progress in the treatment of simple obesity with traditional Chinese medicine compounds

Published on Frontiers in Pharmaceutical Sciences 2025,29(12):2137-2144.
1453 times 218 times

ZHANG Xiali WANG Zhuo MI Li

Simple obesity Traditional Chinese medicine compounding Research progress Leptin resistance Insulin resistance Gut microbiota dysbiosis JAK2-STAT3 signaling pathway PI3K/Akt signaling pathway
Details
Application progress of paraben preservatives in pharmaceutical preparations

Published on Frontiers in Pharmaceutical Sciences 2025,29(12):2145-2153.
1326 times 195 times

YI Qiao WANG Jie YAN Leina

Paraben Antimicrobial effectiveness Safety Methylparaben Ethylparaben Bacteriostat Dosage
Details
Application of hot stage polarizing microscope in the study of drug polymorphism

Published on Frontiers in Pharmaceutical Sciences 2025,29(12):2154-2160.
1101 times 209 times

CHEN Hui WANG Huijie ZHANG Shibo LI Yao WANG Huan ZHOU Hao

Hot stage polarizing microscope Drug polymorphism Characterization of polymorphism Control of polymorphism In-situ research Crystal habit analysis Phase transition kinetics Process optimization
Details
Guide on Methodological Standards in Pharmacoepidemiology (2nd edition) and their series interpretation (13): advances in the application and case studies of systematic review and Meta-analysis

Published on Chinese Journal of Pharmacoepidemiology 2026,35(1):2-16.
787 times 180 times

DIAO Sha HU Yuanhui LIU Jianing LI Hailong ZOU Kun YANG Chunsong BO Zhenyan WEI Yuanxiu YANG Jiayi ZENG Linan ZHANG Lingli

Pharmacoepidemiology Methodology Guidelines Systematic review Meta-analysis
Details
Analysis of factors affecting the blood concentration of piperacillin-tazobactam sodium in patients with severe traumatic brain injury and construction of a prediction model

Published on Chinese Journal of Pharmacoepidemiology 2026,35(1):17-30.
578 times 164 times

CAO Qin WEI Cui CHEN Shenjue GUO Nina

Piperacillin-tazobactam sodium Severe traumatic brain injury Blood drug concentration Influencing factors Prediction model
Details
Clinical efficacy and pharmacoeconomic evaluation of compound Fengshining tablets in treating knee osteoarthritis

Published on Chinese Journal of Pharmacoepidemiology 2026,35(1):31-38.
609 times 172 times

LU Wencan YANG Zili LI Xian

Knee osteoarthritis Compound Fengshining tablets Traditional Chinese medicine syndrome Inflammatory factors Pharmacoeconomics
Details
Multi-dimensional quantitative evaluation of intravenous iron formulations based on A Quick Guideline for Drug Evaluation and Selection in Chinese Medical Institutions (the 2nd edition)

Published on Chinese Journal of Pharmacoepidemiology 2026,35(1):39-50.
672 times 191 times

MU Shengjun XING Zhicong ZHANG Bei SUN Fudong ZHAO Quan

Intravenous iron formulations Iron sucrose Iron dextran Ferric derisomaltose Ferric carboxymaltose Drug selection Drug evaluation
Details
Research on indicators for evaluating the quality of real-world data

Published on Chinese Journal of Pharmacoepidemiology 2026,35(1):62-74.
638 times 179 times

JIE Wan YAO Minghong ZHANG Jun WANG Mingqi JIA Yulong LIU Yanmei WANG Yuning Larry Z. LIU ZOU Kang SUN Xin

Real world study Real world data Quality evaluation Data management Data governance
Details
Efficacy of glucocorticoids on postoperative stress response and complications in patients undergoing liver resection: a Meta-analysis

Published on Chinese Journal of Pharmacoepidemiology 2026,35(1):83-93.
524 times 156 times

GONG Caifang FAN Jing WU Guo LI Jingdong YOU Chuan

Glucocorticoids Hepatectomy Perioperative Infection Systematic review Meta-analysis Randomized controlled trial
Details
Adverse drug reaction; Parmacogenomics; Artificial intelligence; Machine learning; Multi-source heterogeneous; Neural network

Published on Chinese Journal of Pharmacoepidemiology 2026,35(1):104-113.
730 times 168 times

HAN Fangfang LIU Jingxin CHAI Keyan WU Jiarui CAI Yongming

Adverse drug reaction Parmacogenomics Artificial intelligence Machine learning Multi-source heterogeneous Neural network
Details
Immune-related hyperglycemia accompanied by optic neuritis in extensive-stage small cell lung cancer: a case report and pharmaceutical management

Published on Chinese Journal of Pharmacoepidemiology 2026,35(1):114-120.
540 times 151 times

ZHENG Xinyi XU Xin WANG Xiaohang SU Yingjie

Extensive-stage small cell lung cancer Serplulimab Immune-related hyperglycemia Immune-related optic neuritis Immune-related adverse events
Details